IRIS - Res&Arch Institutional Research Information System - Research & Archive

CECCHETTI, Violetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.018
AS - Asia 5.853
EU - Europa 5.791
SA - Sud America 770
AF - Africa 150
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 20.607
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.869
SG - Singapore 2.507
IT - Italia 1.055
UA - Ucraina 901
CN - Cina 884
IE - Irlanda 869
VN - Vietnam 778
RU - Federazione Russa 736
HK - Hong Kong 732
SE - Svezia 659
BR - Brasile 597
DE - Germania 362
FI - Finlandia 270
FR - Francia 263
GB - Regno Unito 199
KR - Corea 197
IN - India 124
BE - Belgio 112
TR - Turchia 111
BD - Bangladesh 85
JP - Giappone 81
PL - Polonia 72
CA - Canada 66
AR - Argentina 60
MX - Messico 59
IQ - Iraq 54
NL - Olanda 46
RO - Romania 45
UZ - Uzbekistan 45
ZA - Sudafrica 41
PK - Pakistan 38
CH - Svizzera 37
SA - Arabia Saudita 36
ES - Italia 35
ID - Indonesia 31
AT - Austria 29
CZ - Repubblica Ceca 26
EC - Ecuador 26
PH - Filippine 25
VE - Venezuela 21
EG - Egitto 20
CO - Colombia 19
MA - Marocco 18
CL - Cile 14
LB - Libano 14
AU - Australia 13
CI - Costa d'Avorio 13
ET - Etiopia 13
AE - Emirati Arabi Uniti 12
KE - Kenya 12
MY - Malesia 12
IL - Israele 11
JO - Giordania 10
LT - Lituania 10
UY - Uruguay 10
BG - Bulgaria 9
TN - Tunisia 9
DZ - Algeria 8
GR - Grecia 8
PY - Paraguay 8
DK - Danimarca 7
EU - Europa 7
IR - Iran 7
KG - Kirghizistan 7
LV - Lettonia 7
NP - Nepal 7
AL - Albania 6
BO - Bolivia 6
PA - Panama 6
PE - Perù 6
OM - Oman 5
RS - Serbia 5
AM - Armenia 4
AZ - Azerbaigian 4
HN - Honduras 4
JM - Giamaica 4
KZ - Kazakistan 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
AO - Angola 3
BY - Bielorussia 3
HR - Croazia 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CR - Costa Rica 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
LY - Libia 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SN - Senegal 2
SV - El Salvador 2
Totale 20.579
Salva come PNG Salva come JPEG
Città #
Singapore 1.843
Chandler 1.091
Dublin 869
San Jose 754
Hong Kong 715
Ashburn 491
Dong Ket 487
Jacksonville 483
Perugia 469
San Mateo 460
Boardman 307
Santa Clara 283
Beijing 209
Moscow 206
Medford 205
Princeton 203
Seoul 193
Lauterbourg 178
Ann Arbor 167
Wilmington 159
Altamura 146
Los Angeles 143
Andover 128
The Dalles 125
Lawrence 123
New York 114
Brussels 112
Ho Chi Minh City 109
Munich 99
Piscataway 80
Fremont 77
Tokyo 73
Des Moines 68
Hanoi 61
São Paulo 60
Saint Petersburg 57
Turku 54
Orem 53
Warsaw 48
West Jordan 48
Dallas 46
Izmir 45
Nanjing 43
Redmond 43
Norwalk 39
Dearborn 36
Brooklyn 35
Helsinki 35
Rome 35
Woodbridge 35
Denver 34
Council Bluffs 33
Atlanta 31
Chicago 27
Falls Church 27
Baghdad 26
Bucharest 25
Columbus 25
Montreal 25
Spoleto 25
Chennai 24
Hefei 24
Poplar 24
San Giustino 23
Shanghai 23
Tashkent 23
Houston 22
San Paolo di Civitate 22
London 21
Phoenix 21
Redwood City 21
Stockholm 21
Buffalo 20
Dhaka 20
Johannesburg 20
Seattle 19
Mexico City 18
San Diego 18
San Francisco 18
Ankara 17
Philadelphia 17
Rio de Janeiro 17
Den Haag 16
Mumbai 16
Charlotte 15
Secaucus 15
Auburn Hills 14
Boston 14
Chongqing 14
Da Nang 14
Manchester 14
Abidjan 13
Curitiba 13
Hanover 13
Olomouc 13
Porto Alegre 13
Addis Ababa 12
Barnet 12
Guangzhou 12
Haiphong 12
Totale 12.918
Salva come PNG Salva come JPEG
Nome #
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 339
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 333
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 320
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 315
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 251
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 204
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 182
Sintesi di nuovi inibitori della pompa di efflusso NorA dello S. aureus: dalle 3-fenil-1,4-benzotiazine alle 2-fenilchinossaline 164
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 162
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 155
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 154
Derivati benzotiazinici come inibitori della pompa estrudente MDR NorA dello Staphylococcus aureus 146
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 145
Attivatori dei canali KATP a struttura 1,4-benzotiazinica. Modificazioni in N-4 144
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 144
New Insights on KCa3.1 Channel Modulation 144
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 143
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 143
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 142
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 141
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 140
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 140
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 138
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 137
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 134
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 134
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 134
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 133
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates 132
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 132
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 129
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 128
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 127
6-Aminoquinolones as New Potential Anti-HIV Agents 126
6-Desfluoroquinolones as promising HIV transcription inhibitors 126
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 126
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 126
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 124
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 124
A Comprehensive Structural Overview of p38 Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders 124
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 123
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 123
S. aureus NorA efflux pump: the discovery of new potent inhibitors 123
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 123
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 120
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 120
Process for the Preparation of 9-Fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic Acid Hydrochloride 118
Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones 117
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 117
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 116
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 116
Bicyclic octahydrocyclohepta[b]pyrrol-4(1H)one derivatives as novel selective anti-hepatitis C virus agents 116
Chemometric rationalization of the structural features affecting the antibacterial activity of quinolones 116
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 115
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 115
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 113
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 113
Enantiomers of 8-(3-tert-Butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H-(1,4)benzothiazine: Racemic Resolution, Chiral Synthesis and Biological Activity. 113
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 112
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 112
A New Derivative with Ultra-Potent Anti-HIV Activity 110
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 110
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 110
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 110
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 109
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 109
Co-crystal structure determination and cellular evaluation of 1,4-dihydropyrazolo[4,3-c] [1,2] benzothiazine 5,5-dioxide p38α MAPK inhibitors 109
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 109
A new 6-aminoquinolone compound with anti-HCMV activity 108
New Heterocyclic Ring Systems. XIII.7,11-Dithiaazasteroid Analogues 107
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 107
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 107
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 106
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 105
The antibacterial activity of quinolones against E.coli: a chemometric study 105
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 104
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 104
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 104
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 103
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 103
Synthesis of Novel Inhibitors of the S. aureus Efflux pumps: from the 4-hydroxy-2-phenylquinolines to the 4-hydroxy-2-phenylquinazolines 103
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 103
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 102
QSAR study and VolSurf characterization of anti-HIV quinolone library 101
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 101
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 101
Chemometric Rationalization of the Structural Features Affecting the Antibacterial Activity of Quinolones Against Staphylococcus aureus 100
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 100
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 100
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 100
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 99
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 98
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 97
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 97
6-Aminoquinolones targeting HCV NS5B polymerase. 97
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 96
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 95
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 95
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 94
One-Pot Synthesis of Rufloxacin 94
Totale 12.938
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021523 0 0 0 0 0 0 0 0 0 0 0 523
2021/20222.004 58 337 42 129 145 17 48 570 88 58 241 271
2022/20233.237 227 527 49 304 282 338 3 164 1.156 24 119 44
2023/20241.396 83 192 68 32 24 39 292 34 171 93 169 199
2024/20253.412 51 287 122 298 403 167 288 193 590 198 543 272
2025/20266.857 494 451 336 883 917 665 1.153 367 738 568 221 64
Totale 21.197